Japan Hemodialysis and Peritoneal Dialysis Market (2024-2029)
The Japan Hemodialysis and Peritoneal Dialysis Market was valued at $7000 Million in 2024 and projected to reach to $10470 Million by 2029, representing a compound annual growth rate of CAGR 8.4%. Japan's hemodialysis and peritoneal dialysis market is positioned for robust growth through 2029, driven by an aging population with increasing chronic kidney disease incidence and Japan's commitment to advanced renal care.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Japan Hemodialysis and Peritoneal Dialysis Market Trends and Insights
- Japan's aging population and rising prevalence of chronic kidney disease are driving demand for both hemodialysis and peritoneal dialysis treatment modalities.
- Japan's advanced healthcare infrastructure and high adoption of dialysis technologies position the country as a significant market within the Asia Pacific region. The Japanese dialysis market benefits from strong reimbursement policies, technological innovation, and a well-established patient base requiring long-term renal replacement therapy.
- Japan's focus on improving quality of life for dialysis patients through home-based and peritoneal dialysis options is expanding treatment accessibility.
- Between 2024 and 2029, Japan is expected to see sustained growth driven by demographic shifts, improved diagnostic capabilities, and increased healthcare spending on end-stage renal disease management..
Key Market Statistics
- CAGR (2024-2029) CAGR 8.4%
- Market Size, 2024 ~USD 7000 Million
- Forecast, 2029 ~USD 10470 Million
- Country Japan
Japan Hemodialysis and Peritoneal Dialysis Market Overview
Aging Population Driving Growth :
Japan's rapidly aging demographic, with over 29% of the population aged 65+, significantly increases chronic kidney disease prevalence and dialysis demand, positioning the market for sustained expansion through 2029.
Strong CAGR Outpacing Global Average :
Japan's hemodialysis and peritoneal dialysis market is growing at 8.4% CAGR, substantially exceeding the global rate of 6.5%, reflecting unique domestic healthcare drivers and treatment adoption patterns.
Advanced Healthcare Infrastructure :
Japan's world-class medical facilities, high treatment accessibility, and sophisticated dialysis center networks support premium service delivery and drive market expansion across both urban and rural regions.
Market Valuation Trajectory :
The market is projected to grow from USD 7,000 million in 2024 to USD 10,470 million by 2029, representing a USD 3,470 million increase in market value over the five-year forecast period.
Japan Hemodialysis and Peritoneal Dialysis Market Dynamics
- The market's 8.4% CAGR reflects strong demand for both treatment modalities, supported by comprehensive insurance coverage, high treatment compliance rates, and continuous technological innovation in dialysis equipment and techniques. Key growth catalysts include rising patient awareness, expansion of dialysis center capacity, and integration of home-based peritoneal dialysis programs.
- Japan's healthcare system prioritizes quality outcomes and patient quality of life, creating opportunities for premium dialysis solutions and personalized treatment approaches.
- Strategic investments in infrastructure and workforce development will further accelerate market penetration across all demographic segments..
Related Ecosystem
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- JOHNSON & JOHNSON
Key Takeaways
- Japan's dialysis market is projected to grow from USD 7,000M in 2024 to USD 10,470M by 2029 at an 8.4% CAGR, outpacing global growth.
- Japan's aging demographic and high prevalence of chronic kidney disease are primary drivers of sustained dialysis demand.
- Japan's robust reimbursement framework and advanced healthcare infrastructure support market expansion and technology adoption.
- Japan's emphasis on home-based and peritoneal dialysis options is improving patient outcomes and expanding market accessibility.
Hemodialysis and Peritoneal Dialysis Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | HOME HEMODIALYSIS SERVICES (Type) |
| Forecast Period | 2024–2029 |
| Growth Rate | CAGR of 6.5% from 2024 to 2029 |
| Largest Segment | CONVENTIONAL LONG-TERM HEMODIALYSIS (Modality) |
| Market Size Base Year (Billions) | ~USD 92.11 (2024) |
| Revenue Forecast (Billions) | ~USD 126.2 (2029) |
| Segments Covered | Product & Service, Type, Material, Flux, Modality, Disease Indication, End User, Modality 2022–2029 |
Japan Hemodialysis and Peritoneal Dialysis Market Report Segmentation
8 segment dimensions are covered across the global market.
By Product & Service
- Hemodialysis Products
- Hemodialysis Services
- Peritoneal Dialysis Products
- Peritoneal Dialysis Services
By Type
- Access Products
- Acidic Concentrates
- Alkaline Concentrates
- Av Fistula Needles
- Av Grafts
- Bloodlines
- Catheters
- Center-Use Hemodialysis Machines
- Central Venous Catheters
- Central Water Disinfectant Systems
- Central Water Disinfection Systems
- Concentrates /Dialysates
- Concentrates/Dialysates
- Dialyzers
- Hemodialysis Consumables & Supplies
- Hemodialysis Machines
- Home Hemodialysis Services
- Home-Use Hemodialysis Machines
- In-Center Hemodialysis Services
- Machines
- Other Hemodialysis Consumables & Supplies
- Other Peritoneal Dialysis Products
- Peritoneal Dialysis Catheters
- Peritoneal Dialysis Concentrates /Dialysates
- Peritoneal Dialysis Concentrates/Dialysates
- Peritoneal Dialysis Machines
- Peritoneal Dialysis Transfer Sets
- Portable Dialysis Water Disinfectant Systems
- Portable Water Disinfectant Systems
- Portable Water Disinfection Systems
- Transfer Sets
By Material
- Cellulose-Based Dialyzers
- Synthetic Dialyzers
By Flux
- High-Flux Dialyzers
- Low-Flux Dialyzers
By Modality
- Automated Peritoneal Dialysis
- Continuous Ambulatory Peritoneal Dialysis
- Conventional Long-Term Hemodialysis
- Long-Term Hemodialysis
- Nocturnal Hemodialysis
- Short Daily Hemodialysis
By Disease Indication
- Acute Kidney Injury
- End-Stage Renal Disease
- Other Diseases
By End User
- Home Care Settings
- Hospitals
- Independent Dialysis Centers
- Other End Users
By Modality 2022–2029
- Conventional Long-Term Hemodialysis
- Nocturnal Hemodialysis
- Short Daily Hemodialysis
Target Audience
- Dialysis Equipment Manufacturers : Manufacturers need Japan-specific market data to assess demand for hemodialysis and peritoneal dialysis equipment, identify growth opportunities in the aging population segment, and develop localized product strategies for the high-value Japanese market.
- Healthcare Facility Operators : Dialysis center operators and hospital networks require detailed market forecasts to plan capacity expansion, optimize treatment modality mix, and allocate resources effectively across Japan's growing patient population through 2029.
- Pharmaceutical and Biotech Companies : Drug developers and biotech firms need Japan market intelligence to identify opportunities for dialysis-related therapeutics, assess market size for renal disease treatments, and plan clinical trial and commercialization strategies.
- Healthcare Investors and Private Equity : Investment firms require Japan dialysis market data to evaluate acquisition targets, assess portfolio company growth potential, and identify high-return investment opportunities in the expanding USD 10,470M market by 2029.
- Healthcare Policy and Government Agencies : Government health ministries and policy makers need market forecasts to plan healthcare infrastructure investments, allocate reimbursement budgets, and develop strategies addressing chronic kidney disease burden in Japan's aging society.
Key Companies in the Japan Hemodialysis and Peritoneal Dialysis Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| KINDRED HEALTHCARE INC. | United States | Private Company | Injectable and infusion-based drug administration in long-term acute care hospitals,Oral drug administration and regimen management in inpatient rehabilitation facilities,Topical, inhaled, and other specialized administration routes in contract rehabilitation services, |
| NOLATO | Sweden | Public Company | Medical components and assemblies,Pharmaceutical primary packaging,Labware and TreffLab products, |
| SHIMADZU CORPORATION | Japan | Public Company | Analytical and Measuring Instruments,Medical Systems,Vacuum and Industrial Machinery, |
| MERIT MEDICAL | United States | Public Company | Cardiovascular – Peripheral Intervention (angiography, drainage, delivery, embolotherapy),Cardiovascular – Cardiac Intervention (access, angiography, EP/CRM, fluid and hemodynamic management),Access & Safety (micropuncture kits, needles, sheaths, guide wires, safety products), |
| STERIS CORPORATION | United States | Public Company | Healthcare (hospital capital equipment, chemistries, and services),Applied Sterilization Technologies (contract sterilization and related services),Life Sciences (pharma/biopharma detergents, disinfectants, sterilizers, and services), |
| FRESENIUS MEDICAL CARE AG | Germany | Public Company | Care Delivery (outpatient and hospital dialysis services),Hemodialysis machines and disposables,Peritoneal dialysis systems and solutions, |
| BAXTER | United States | Public Company | Medical Products & Therapies (IV, infusion, parenteral nutrition, renal and related),Healthcare Systems & Technologies (smart beds, monitoring, OR integration, surgical equipment),Pharmaceuticals (generic and specialty injectables, inhaled anesthetics, compounding), |
| DAVITA INC. | United States | Public Company | In-center outpatient dialysis services,Hospital inpatient dialysis services,Home-based hemodialysis and peritoneal dialysis, |
| NIKKISO CO., LTD. | Japan | Public Company | Industrial pumps and systems (including cryogenic),Cryogenic heat transfer and process equipment,Precision equipment and industrial systems, |
| MEDTRONIC | Ireland | Public Company | Cardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Diabetes), |
| ASAHI KASEI CORPORATION | Japan | Public Company | Advanced materials for electronics and energy (semiconductor materials, Hipore, Celgard, optical fiber, sensors),Homes, construction systems, and real estate,Healthcare (pharma, devices, virus removal filters, data systems), |
| TERUMO CORPORATION | Japan | Public Company | Cardiac and Vascular Company,Medical Care Solutions Company,Blood and Cell Technologies Company, |
| NIPRO CORPORATION | Japan | Public Company | Dialysis and renal consumables,Injection and infusion disposables,Cardiovascular and interventional devices, |
| ROCKWELL MEDICAL, INC. | United States | Public Company | Acid concentrates (Citrapure, RenalPure, Dri-Sate),Bicarbonate concentrates and cartridges (RenalPure, Sterilyte),Dialysis kits and integrated concentrate systems, |
| BECTON, DICKINSON AND COMPANY | United States | Public Company | Medical Essentials (needles, syringes, vascular access, sharps, specimen collection),Connected Care (infusion, medication management, pharmacy automation, informatics),BioPharma Systems (prefillable drug delivery systems), |
KINDRED HEALTHCARE INC.
Kindred Healthcare Inc. is a United States-based private healthcare company founded in 1985, operating with a workforce of 64,200 employees.
NOLATO
Nolato is a Swedish public company founded in 1938 with 5,607 employees, specializing in medical and healthcare-related manufacturing.
SHIMADZU CORPORATION
Shimadzu Corporation is a Japanese public company established in 1875 with 14,649 employees, operating in the medical and analytical instrumentation sectors.
MERIT MEDICAL
Merit Medical is a United States-based public company founded in 1987 with 7,500 employees, specializing in medical devices and healthcare products.
STERIS CORPORATION
Steris Corporation is a United States-based public company founded in 1985 with 17,937 employees, providing sterilization and healthcare solutions.
FRESENIUS MEDICAL CARE AG
Fresenius Medical Care AG is a German public company founded in 1996 with 108,165 employees, operating as a major provider of dialysis and renal care services.
BAXTER
Baxter is a United States-based public company founded in 1931 with 37,500 employees, specializing in medical devices, pharmaceuticals, and healthcare products.
DAVITA INC.
DaVita Inc. is a United States-based public company founded in 1994 with 78,000 employees, operating as a leading provider of dialysis and kidney care services.
NIKKISO CO., LTD.
Nikkiso Co., Ltd. is a Japanese public company founded in 1950 with 8,120 employees, manufacturing medical devices and healthcare equipment.
MEDTRONIC
Medtronic is an Ireland-based public company founded in 1949 with 95,000 employees, operating as a global leader in medical technology and healthcare devices.
ASAHI KASEI CORPORATION
Asahi Kasei Corporation is a Japanese public company founded in 1922 with 47,895 employees, operating in healthcare, chemicals, and materials sectors.
TERUMO CORPORATION
Terumo Corporation is a Japanese public company founded in 1921 with 30,591 employees, specializing in medical devices and healthcare products.
NIPRO CORPORATION
Nipro Corporation is a Japanese public company founded in 1954, specializing in medical devices and healthcare solutions.
ROCKWELL MEDICAL, INC.
Rockwell Medical, Inc. is a United States-based public company founded in 1996 with 157 employees, specializing in medical devices and healthcare solutions.
BECTON, DICKINSON AND COMPANY
Becton, Dickinson and Company is a United States-based public company founded in 1897 with 72,000 employees, operating as a global leader in medical devices and healthcare products.
Reasons to Buy this Report
- Japan-Specific Market Sizing : Access precise valuation data for Japan's dialysis market with verified 2024 baseline (USD 7,000M) and 2029 forecast (USD 10,470M), enabling accurate financial planning and investment decisions tailored to the Japanese market.
- Competitive Positioning Intelligence : Understand Japan's unique market dynamics, aging population impact, and healthcare infrastructure advantages to identify competitive opportunities and differentiation strategies specific to Japanese dialysis providers and suppliers.
- Growth Rate Benchmarking : Leverage Japan's 8.4% CAGR data to benchmark performance against global 6.5% growth, identify outperformance drivers, and develop targeted expansion strategies for the high-growth Japanese market.
- Regulatory and Healthcare System Insights : Gain deep understanding of Japan's advanced healthcare infrastructure, insurance coverage models, treatment accessibility patterns, and regulatory environment specific to dialysis market operations and expansion.
- Strategic Investment Guidance : Make informed capital allocation decisions with comprehensive Japan market analysis, identifying optimal entry points, partnership opportunities, and growth segments within the USD 3,470M market expansion opportunity.
Frequently asked questions
What is the current size of Japan's hemodialysis and peritoneal dialysis market?
Japan's hemodialysis and peritoneal dialysis market was valued at USD 7,000 million in 2024 and is expected to reach USD 10,470 million by 2029.
What is the projected growth rate for Japan's dialysis market?
Japan's dialysis market is projected to grow at a compound annual growth rate of 8.4% from 2024 to 2029.
What factors are driving growth in Japan's dialysis market?
Japan's dialysis market growth is driven by an aging population, rising chronic kidney disease prevalence, strong reimbursement policies, and technological innovation in treatment modalities.
How does Japan's dialysis market compare to global trends?
Japan's dialysis market CAGR of 8.4% exceeds the global CAGR of 6.5%, reflecting Japan's demographic challenges and advanced healthcare infrastructure.
What treatment options are expanding in Japan's dialysis market?
Japan is increasingly adopting home-based hemodialysis and peritoneal dialysis options to improve patient quality of life and expand treatment accessibility.
RESEARCH METHODOLOGY
This research study extensively utilized both primary and secondary sources. It involved analyzing various factors influencing the industry to identify segmentation types, industry trends, key players, the competitive landscape, key market dynamics, and strategies employed by key players.
Secondary Research
The research methodology for estimating and forecasting the data center cooling CDU pumps market begins with gathering data on key vendors' revenues by doing secondary research. The secondary research process involves consulting a range of secondary sources, including Hoover's, Bloomberg Businessweek, Factiva, the World Bank, and industry-specific journals. These secondary sources encompass annual reports, press releases, investor presentations, white papers, certified publications, articles from recognized authors, regulatory notifications, trade directories, and databases. Also, vendor offerings are taken into consideration to inform market segmentation.
Primary Research
Primary research for this study was conducted with leading participants across the hemodialysis and peritoneal dialysis value chain. On the supply side, discussions were held with project managers, regional sales managers, product directors, vice presidents of marketing, chief executive officers, and chief information officers at hemodialysis machine manufacturers, dialyzer manufacturers, PD cycler suppliers, consumables providers, water treatment system vendors, and dialysis service operators. On the demand side, interviews were conducted with nephrologists, dialysis center directors, renal care procurement managers, hospital administrators, home dialysis program coordinators, and clinical nursing staff responsible for patient training in home hemodialysis and peritoneal dialysis settings. These interviews were used to validate market size estimates, corroborate segmentation assumptions, and capture the latest commercial dynamics across in-center, home, and acute dialysis care settings.
Note 1: C-level executives include CEOs, COOs, CTOs, and VPs.
Note 2: Other designations include sales, marketing, and product managers.
Note 3: Tiers are defined based on a company’s total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The total size of the hemodialysis & peritoneal dialysis market was determined after data triangulation from three approaches, as mentioned below. After each approach, the weighted average of the three approaches was taken based on the level of assumptions used in each approach.
Data Triangulation
After arriving at the overall market size using both the market size estimation processes described above, the total market was split into several segments and subsegments. To complete the overall market estimation process and ascertain exact statistics for all segments and subsegments, data triangulation and market breakdowns were applied wherever applicable. The data was triangulated by examining various factors and trends on both the demand and supply sides of the hemodialysis and peritoneal dialysis markets.
Market Definition
The global hemodialysis and peritoneal dialysis market encompasses the revenues generated from the sale and provision of products, equipment, and services used to deliver renal replacement therapy to patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD), as well as patients with acute kidney injury (AKI) requiring short-term dialysis support. On the hemodialysis side, the market includes center-use and home-use hemodialysis machines, hemodialysis consumables and supplies (dialyzers, bloodlines and tubing sets, concentrates and dialysates, vascular access products, and other consumables), water treatment systems for dialysis centers (central and portable water disinfection systems), and in-center and home hemodialysis services.
Key Stakeholders
- Hemodialysis and peritoneal dialysis machine manufacturers
- Dialyzer and hollow-fiber membrane manufacturers
- HD consumables and PD product suppliers (bloodlines, concentrates, dialysates, catheters, transfer sets)
- Vascular access device manufacturers (AV fistula needles, tunneled catheters, grafts)
- Dialysis water treatment system providers
- In-center dialysis service operators and dialysis chain operators (independent and hospital-affiliated)
- Home dialysis program providers and care management platforms
- Nephrologists, renal care nurses, and clinical dietitians
- Hospital procurement managers and group purchasing organizations (GPOs)
- Government health agencies and reimbursement bodies (CMS, NHS, NHI programs)
- Regulatory authorities (US FDA, EMA, CDSCO, PMDA, TGA)
- Academic and clinical research institutions focused on nephrology and renal replacement therapy
Report Objectives
- To define, describe, segment, and forecast the hemodialysis & peritoneal dialysis market by product & services, disease indication, end user, and region
- To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall hemodialysis & peritoneal dialysis market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the hemodialysis & peritoneal dialysis market in five main regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile the key players in the hemodialysis & peritoneal dialysis market and comprehensively analyze their core competencies and market shares
- To track and analyze competitive developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships
Available customizations:
Available Customizations
With the given market data, MarketsandMarkets offers customizations to meet your company’s specific needs. The following customization options are available for the report:
Company Information- Detailed analysis and profiling of additional market players (up to 5)
-
Further breakdown of the Rest of Europe hemodialysis & peritoneal dialysis market into Austria, Finland, Switzerland, and other countries
Further breakdown of the Rest of Latin America hemodialysis & peritoneal dialysis market into Colombia, Chile, and other countries
- Market share analysis for North America and Europe, which provides market shares of the top 3–5 key players in the Hemodialysis & Peritoneal Dialysis market
- Competitive leadership mapping for established players in the US
Get the Full Hemodialysis and Peritoneal Dialysis Market Report
Full forecast, segment splits, and company analysis for all Hemodialysis and Peritoneal Dialysis Market.
- Canada Hemodialysis and Peritoneal Dialysis Market
- US Hemodialysis and Peritoneal Dialysis Market
- Germany Hemodialysis and Peritoneal Dialysis Market
- UK Hemodialysis and Peritoneal Dialysis Market
- France Hemodialysis and Peritoneal Dialysis Market
- Italy Hemodialysis and Peritoneal Dialysis Market
- Spain Hemodialysis and Peritoneal Dialysis Market
- China Hemodialysis and Peritoneal Dialysis Market
- India Hemodialysis and Peritoneal Dialysis Market
- Australia Hemodialysis and Peritoneal Dialysis Market
- South Korea Hemodialysis and Peritoneal Dialysis Market
- Brazil Hemodialysis and Peritoneal Dialysis Market
- Mexico Hemodialysis and Peritoneal Dialysis Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report